Skip to search.
 STI Up 2.53%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
0.63 Down 0.03(4.58%) 6 Feb 05:00 SGT
Prev Close:0.66
Open:0.67
Bid:0.05 x 200
Ask:1.53 x 200
1y Target Est:3.92
Beta:1.48501
Next Earnings Date:10-Mar-16GALE Earnings announcement
Day's Range:0.62 - 0.68
52wk Range:0.59 - 2.39
Volume:1,160,072
Avg Vol (3m):1,559,200
Market Cap:114.44M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GALEDown 4.58%114.44M
CELGDown 3.96%76.91B
VSTMDown 5.04%41.74M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Dec-15) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback